| 产品详情 |
| Edit |   |
|---|
| Product Name | NCI-H69/LX4 |
|---|
| Description | NCI-H69/LX4 has been established by exposure of the parent line, H69 to doxorubicin, also known as adriamycin. The line hyperexpresses P-glycoprotein and demonstrates a multidrug resistant drug accumulation deficit. It is recommended to culture the cells without drug after resuscitation until the first passage. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | CSC-C9516J |
|---|
| Price | |
|---|
| Order / More Info | NCI-H69/LX4 from CREATIVE BIOARRAY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|